Phreesia, Inc. (NYSE:PHR) Stock Has Consensus Target Price of $14.00

Shares of Phreesia, Inc. (NYSE:PHR) have received an average recommendation of “Hold” from the nineteen ratings firms that are currently covering the stock, MarketBeat.com reports. One equities research analyst has rated the stock with a sell recommendation, ten have issued a hold recommendation and eight have issued a buy recommendation on the company. The average 12 month price objective among brokers that have updated their coverage on the stock in the last year is $14.00.

Several research analysts have issued reports on the company. Royal Bank Of Canada reiterated an “outperform” rating and issued a $19.00 price objective on shares of Phreesia in a research report on Thursday, September 3rd. Needham & Company LLC restated a “buy” rating and set a $14.00 target price on shares of Phreesia in a research report on Monday, August 31st. Wall Street Zen cut Phreesia from a “buy” rating to a “hold” rating in a report on Saturday, September 5th. Citigroup reaffirmed a “market perform” rating on shares of Phreesia in a research note on Friday, September 4th. Finally, Canaccord Genuity Group reiterated a “buy” rating and set a $16.00 target price on shares of Phreesia in a research report on Thursday, September 3rd.

Insider Transactions at Phreesia

In other Phreesia news, General Counsel Allison C. Hoffman sold 6,662 shares of the company’s stock in a transaction dated Monday, September 21st. The shares were sold at an average price of $10.08, for a total value of $67,152.96. Following the sale, the general counsel owned 266,574 shares of the company’s stock, valued at $2,687,065.92. This represents a 2.44% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders own 5.20% of the company’s stock.

Institutional Inflows and Outflows

A number of hedge funds have recently modified their holdings of the business. Sequoia Financial Advisors LLC purchased a new stake in Phreesia in the 2nd quarter valued at approximately $159,000. Integrated Wealth Concepts LLC boosted its stake in shares of Phreesia by 37.2% during the second quarter. Integrated Wealth Concepts LLC now owns 14,129 shares of the company’s stock valued at $145,000 after acquiring an additional 3,834 shares during the last quarter. Allworth Financial LP increased its position in Phreesia by 78.3% during the 2nd quarter. Allworth Financial LP now owns 5,613 shares of the company’s stock worth $58,000 after purchasing an additional 2,465 shares in the last quarter. Corient Private Wealth LP raised its stake in Phreesia by 451.7% in the 2nd quarter. Corient Private Wealth LP now owns 148,290 shares of the company’s stock valued at $1,526,000 after purchasing an additional 121,413 shares during the last quarter. Finally, VIRGINIA RETIREMENT SYSTEMS ET Al acquired a new position in Phreesia in the 2nd quarter valued at about $1,038,000. 92.10% of the stock is owned by hedge funds and other institutional investors.

Phreesia Stock Up 2.6%

PHR stock opened at $10.51 on Friday. The stock has a market capitalization of $652.54 million, a PE ratio of 61.84 and a beta of 0.84. The company has a fifty day moving average of $11.05 and a 200-day moving average of $10.20. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.76 and a current ratio of 1.76. Phreesia has a one year low of $7.77 and a one year high of $24.25.

Phreesia (NYSE:PHR) last posted its quarterly earnings results on Wednesday, September 2nd. The company reported $0.03 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.09 by ($0.06). Phreesia had a return on equity of 5.22% and a net margin of 2.06%.The firm had revenue of $129.46 million for the quarter, compared to analysts’ expectations of $129.06 million. During the same period in the prior year, the company earned $0.01 earnings per share. The company’s revenue for the quarter was up 10.4% on a year-over-year basis. As a group, analysts expect that Phreesia will post 0.33 EPS for the current year.

Phreesia Company Profile

Phreesia, Inc is a healthcare technology company that provides software and services designed to simplify and automate the patient intake process. Its platform helps healthcare organizations manage registration, consent forms, clinical questionnaires, insurance and demographic information, payments, and other administrative tasks through digital tools.

The company’s offerings are used by medical practices, health systems, and other healthcare organizations to improve patient engagement and support administrative and revenue-cycle workflows.